Anti‐tumor effects of PIM / PI 3K/ mTOR triple kinase inhibitor IBL ‐302 in neuroblastoma

Mohlin S, Hansson K, Radke K, Martinez S, Blanco‐Apiricio C, Garcia‐Ruiz C, Welinder C, Esfandyari J, O'Neill M, Pastor J, Stedingk K, Bexell D

EMBO Mol Med - (-) - [2019-07-16; online 2019-07-16]

NGI Uppsala (Uppsala Genome Center) [Service]

National Genomics Infrastructure [Service]

QC bibliography QC xrefs

DOI 10.15252/emmm.201810058

Crossref 10.15252/emmm.201810058